(Q44813874)

English

COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study (English)

1 reference

Europe PubMed Central

6 December 2017

Joseph K. McLaughlin

5

object named as

McLaughlin JK

1 reference

Europe PubMed Central

6 December 2017

author name string

Nørgård B

1

1 reference

Europe PubMed Central

6 December 2017

Pedersen L

2

1 reference

Europe PubMed Central

6 December 2017

Johnsen SP

3

1 reference

Europe PubMed Central

6 December 2017

Tarone RE

4

1 reference

Europe PubMed Central

6 December 2017

Friis S

6

1 reference

Europe PubMed Central

6 December 2017

Sørensen HT

7

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

6 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

6 December 2017

19

1 reference

Europe PubMed Central

6 December 2017

7

1 reference

Europe PubMed Central

6 December 2017

817-825

1 reference

Europe PubMed Central

6 December 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

The relationship between cyclooxygenase-2 expression and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Are selective COX 2 inhibitors superior to traditional NSAIDs? Rofecoxib did not provide unequivocal benefit over traditional NSAIDs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Validation of diagnoses of peptic ulcers and bleeding from administrative databasesA multi-health maintenance organization study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01913.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.01913.X

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44813874&oldid=2046945378"